These U.S. stocks have been hit hardest amid Turkey’s turmoil
Most of the worst S&P 500 performers derive significant sales from outside the U.S. See full story.
Boost from Elon Musk expanding on his plan to take Tesla private proves to be short lived. See full story.
U.S. negotiators were naïve to expect that a deal with the EU would radically redress the $150 billion trade deficit with Europe, writes Peter Morici. See full story.
Momentum could be pointing to big gains going forward for these sectors — regardless of how long the S&P takes to break out. See full story.
Pharmacy-benefit managers may drive hard bargains with drug manufacturers, but they keep finding ways to boost their bottom line at the expense of employers and patients. See full story.
A generous first-year bonus depreciation break can be a huge tax saving benefit for small businesses. See full story.
Want a summary of the top news? Subscribe to MarketWatch's free Midday Report newsletter. Sign up here.
Source: Read Full Article